Related Subjects:
|Vitamin D Replacement
|Osteomalacia-Rickets-Vitamin D
|Vitamin D resistant rickets
|Vitamin D (25 OH D) Testing
|X linked Hypophosphataemic rickets
|Osteoporosis
𦴠In Hypophosphatemic Rickets, defective renal phosphate reabsorption causes chronic phosphate wasting and hypophosphatemia. Unlike nutritional rickets, patients typically do not respond to standard Vitamin D therapy.
π About
- Hypophosphatemic Rickets (also called Vitamin DβResistant Rickets) is a disorder of mineral metabolism caused by renal phosphate wasting.
- Inheritance is most commonly X-linked dominant (mutation in the PHEX gene). Autosomal recessive and sporadic forms exist.
- Most patients present in childhood with rickets that fails to improve despite Vitamin D supplementation.
𧬠Renal Tubular (RT) Forms
- Type I: Defect in renal 1-alpha-hydroxylase, leading to inadequate conversion of 25(OH)D β 1,25(OH)2D.
- Type II: End-organ resistance to active Vitamin D (1,25(OH)2D).
- Both are treated with high doses of calcitriol (active Vitamin D).
βοΈ Aetiology & Pathophysiology
- π§ͺ Defective phosphate reabsorption in the proximal renal tubules β urinary phosphate wasting.
- β¬οΈ Serum phosphate β impaired bone mineralisation β rickets/osteomalacia.
- Frequently associated with elevated FGF23 (fibroblast growth factor-23), a hormone that suppresses phosphate reabsorption and 1-alpha-hydroxylase activity.
π©Ί Clinical Features
- πΆ Presents in infancy or early childhood.
- π Short stature & growth failure.
- 𦡠Bowed legs (genu varum) or knock knees (genu valgum).
- π¦· Dental problems: delayed dentition, spontaneous abscesses.
- Other possible features:
- π Deafness
- π§ Chiari malformation
- π Craniosynostosis
- πͺ¨ Calcification of ligaments, tendons, and joint capsules
- πͺ₯ Renal stones or nephrocalcinosis
π Investigations
- β¬οΈ Serum phosphate
- β¬οΈ Alkaline phosphatase (ALP)
- β¬οΈ Urinary phosphate excretion
- β¬οΈ or normal calcium
- β¬οΈ Parathyroid hormone (secondary hyperparathyroidism)
- Normal 25(OH)D but impaired 1,25(OH)2D
- Renal USS: may reveal nephrocalcinosis or stones
- Genetic testing for PHEX mutation in suspected familial cases
βοΈ Management
- π Oral phosphate supplements (divided doses to minimise GI upset).
- π Calcitriol or alfacalcidol (active Vitamin D) to bypass renal conversion defects.
- 𧬠Burosumab (anti-FGF23 monoclonal antibody): NICE-approved for X-linked hypophosphatemia, improves phosphate reabsorption and bone health.
- π Growth hormone therapy in selected cases with severe growth retardation.
- π§ Amiloride or thiazides: may help reduce calcium excretion and prevent nephrocalcinosis.
- 𦴠Supportive: orthopaedic surgery for severe deformities, dental surveillance.
π‘ Exam Pearls
- π§ͺ Distinguish from nutritional rickets: here, Vitamin D is normal but phosphate is low.
- 𧬠X-linked dominant inheritance β fathers cannot pass to sons, but all daughters are affected.
- 𦡠Persistent bowed legs despite Vitamin D therapy is a red flag.
- π Burosumab is a game-changer in modern management.
π References
- NHS β Vitamin D Resistant Rickets
- Carpenter TO. X-linked hypophosphatemia. J Bone Miner Res. 2012;27(10):1983β1998.
- NICE Guidance (TA581): Burosumab for treating X-linked hypophosphataemia in children and young people.